UGT2B7 Substrates with a Narrow Therapeutic Index
- Name
- UGT2B7 Substrates with a Narrow Therapeutic Index
- Accession Number
- DBCAT004613
- Description
Not Available
- Drugs
Drug Drug Description Mycophenolic acid An immunosuppressant used to prevent organ transplant rejections. Valproic acid An anticonvulsant used to control complex partial seizures and both simple and complex absence seizures. Enasidenib An isocitrate dehydrogenase-2 inhibitor used to treat relapsed or refractory acute myeloid leukemia with an isocitrate dehydrogenase-2 mutation. Epirubicin An anthracycline topoisomerase II inhibitor used as an adjuvant to treating axillary node metastases in patients who have undergone surgical resection of primary breast cancer. Tamoxifen A selective estrogen receptor modulator used to treat estrogen receptor positive breast cancer, reduce the risk of invasive breast cancer following surgery, or reduce the risk of breast cancer in high risk women. Carbamazepine An anticonvulsant used to treat various types of seizures and pain resulting from trigeminal neuralgia. Cobimetinib An antineoplastic agent and selective inhibitor of the mitogen-activated extracellular kinase (MEK) pathway used to treat unresectable or metastatic melanoma. - Drugs & Drug Targets